Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
The proportion of U.S. men with early, slow-growing prostate cancer who received robotic surgery and other expensive treatments increased between 2004 and 2009, according to a new study.
Researchers found that use of those therapies also rose among men who were unlikely to die from prostate cancer because they were sick with other chronic diseases when their cancer was diagnosed.
No comment yet.
Sign up to comment
Scoop.it!
An expensive prostate cancer radiation treatment known as proton beam therapy has just as many side effects as a more common and cheaper radiation method, according to a new study.
In terms of side effects, "In the long term, there's really no difference in outcomes between proton radiation and IMRT for men with prostate cancer," said lead author Dr. James Yu, a radiation oncologist at Yale University School of Medicine in New Haven, Connecticut.
Scoop.it!
In this issue of Stem Cell Pioneers 'Ask the Doctor,' our cofounder Terry Grossman M.D. discusses hormone replacement and stem cell therapy.
Read his Q&A to learn more about topics such as:
>Is it worth banking your stem cells? How is this accomplished?
>Should men with prostate cancer take testosterone?
>Is hormone replacement therapy a good idea for everyone?
|
Scoop.it!
Brian Shields's curator insight,
April 14, 2013 11:02 AM
A great advancement may be on the horizon for the treatment of patients with Prostate Cancer. The use of circulating tumor cells or "liquid biopsies" may prevent the need for painful and invasive procedures to obtain biopsy tissue.
Scoop.it!
Animal studies have been conducted successfully using gold nanoparticles to target prostate cancer tumors. Next step-- human trials...
Current treatments for prostate cancer are not effective in patients who have aggressive prostate cancer tumors. Most of the time, prostate cancers are slow-growing; the disease remains localized and it is easily managed. However, aggressive forms of the disease spread to other parts of the body, and is the second-leading cause of cancer deaths in U.S. men.
The MU scientists believe their treatment will be able to shrink aggressive tumors or eliminate them completely. Axiak-Bechtel says this treatment can be safe and effective in dogs as well as humans because dogs are the only other mammal to naturally contract the aggressive form of prostate cancer.
|
